Professor of Systems Biology, Columbia University
Managing Partner at Pappas Ventures
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Managing director, the Foundry Group
Kim Janda, a professor of chemistry and immunology at The Scripps Research Institute, has spent more than 25 years working to bring this type of vaccine to fruition. Janda will differentiate the myths versus the realities while sharing the roadblocks his research has faced in regards to consistency, efficacy and marketability. He will also provide insight into what is on the horizon for the challenging field of addiction research and the breakthroughs his lab is currently making. More information and online registration is here.